Clinical assessment of breast symmetry and aesthetic outcome: can 3D imaging be the gold standard?

Lucy Baia Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
View further author information

Ola Lundströmb Department of Medical Imaging, Karolinska University Hospital, Stockholm, SwedenView further author information

Hemming Johanssona Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenView further author information

Farid Meybodic Westmead Breast Cancer Institute, Westmead, Australia;d Sydney University, Sydney, AustraliaView further author information

Brita Arvera Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenView further author information

Kerstin Sandeline Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, SwedenView further author information

Marie Wickmane Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;f Sophiahemmet University, Stockholm, SwedenView further author information

Yvonne Brandberga Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenView further author information

show all

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Clinical assessment of breast symmetry and aesthetic outcome: can 3D imaging be the gold standard?

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical assessment of breast symmetry and aesthetic outcome: can 3D imaging be the gold standard?

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date